Bioventus Inc. Class A Common Stock
BVSStock
$12.43+81.36%52W
Market Cap$999.91M
P/E43.99x
Div yield—
Beta0.72
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)47.83%
Price vs S&P 500 (4W)36.67%
VGM Score62.03
Market Capitalization$999.91M
P/E Ratio (Annual)43.99x
Earnings Surprise History
Q1 260.15est. 0.10
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.11
4.11
4.11
4.11
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BVSBioventus Inc. Class A Common Stock | B | C | B | $12.43 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Bioventus Inc. is a medical technology company that develops clinically differentiated treatments enhancing natural healing processes across the orthopedic continuum. Its product portfolio serves multiple orthopedic specialties—including sports medicine, joint reconstruction, trauma, and spine surgery—organized into three verticals: Pain Treatments, Surgical Solutions, and Restorative Therapies. The company generates key revenue in the United States with growing international market presence.